{
    "xml": "<topic id=\"PHP5930\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/romiplostim\" basename=\"romiplostim\" title=\"ROMIPLOSTIM\">\n<title>ROMIPLOSTIM</title>\n<body>\n<data name=\"vtmid\">441077008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_192538753\" title=\"Thrombopoietin receptor agonists\">Thrombopoietin receptor agonists</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP60723\" outputclass=\"indicationsAndDose\" rev=\"1.25\" parent=\"/drugs/romiplostim\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of chronic idiopathic thrombocytopenic purpura in splenectomised patients refractory to other treatments (such as corticosteroids or immunoglobulins) (under expert supervision)</p>\n<p outputclass=\"therapeuticIndication\">Second-line treatment of chronic idiopathic thrombocytopenic purpura in non-splenectomised patients when surgery is contra-indicated (under expert supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1&#8239;microgram/kg once weekly, adjusted in steps of 1&#8239;microgram/kg once weekly (max. per dose 10&#8239;micrograms/kg once weekly) until a stable platelet count of 50x10<sup>9</sup> /litre or more is reached, discontinue treatment if inadequate response after 4 weeks at maximum dose, consult product literature for dose adjustments.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60649\" outputclass=\"sideEffects\" rev=\"1.9\" parent=\"/drugs/romiplostim\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arthralgia</ph>; <ph outputclass=\"sideEffect\">asthenia</ph>; <ph outputclass=\"sideEffect\">bone pain</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">ecchymosis</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">increased bone marrow reticulin</ph>; <ph outputclass=\"sideEffect\">influenza-like symptoms</ph>; <ph outputclass=\"sideEffect\">injection site reactions</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">migraine</ph>; <ph outputclass=\"sideEffect\">muscle spasm</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">oedema</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">rash</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60689\" outputclass=\"pregnancy\" parent=\"/drugs/romiplostim\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if essential&#8212; toxicity in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60802\" outputclass=\"breastFeeding\" parent=\"/drugs/romiplostim\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60739\" outputclass=\"hepaticImpairment\" parent=\"/drugs/romiplostim\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in moderate or severe impairment unless potential benefit outweighs risk (e.g. of portal vein thrombosis).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60677\" outputclass=\"renalImpairment\" parent=\"/drugs/romiplostim\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60562\" outputclass=\"monitoringRequirements\" parent=\"/drugs/romiplostim\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor full blood count and peripheral blood smears for morphological abnormalities before and during treatment.</p>\n<p>Monitor platelet count weekly until 50x10<sup>9</sup> /litre or more for at least 4 weeks without dose adjustment, then monthly thereafter.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60684\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/romiplostim\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundDrivingAndOtherTasks\">\n<title>Driving and skilled tasks</title>\n<sectiondiv>\n<p>Dizziness may affect performance of skilled tasks (e.g. driving).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60470\" outputclass=\"nationalFunding\" rev=\"1.18\" parent=\"/drugs/romiplostim\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA221</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (April 2011)</p>\r\n<p>Romiplostim is recommended for the treatment of chronic immune (idiopathic) thrombocytopenic purpura in adults:</p>\r\n<ul>\r\n<li>if the manufacturer provides romiplostin at the agreed discount as part of the patient access scheme <i>and</i>\r\n</li>\r\n<li>whose condition is refractory to standard active treatments and rescue therapies <i>or</i>\r\n</li>\r\n<li>who have severe disease and a high risk of bleeding that needs frequent courses of rescue therapies.</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA221\">www.nice.org.uk/TA221</xref>\n</sectiondiv>\n</sectiondiv>\r\n<sectiondiv outputclass=\"smcDecisions\">\r\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\r\n<sectiondiv outputclass=\"smcDecision\">\r\n<sectiondiv>\r\n<p>The <i>Scottish Medicines Consortium</i> has advised (September 2009) that romiplostim (<i>Nplate</i>\r\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland for patients with severe symptomatic idiopathic thrombocytopenic purpura or those at high risk of bleeding.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP5930-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/romiplostim\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74655\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/romiplostim/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78556\" namespace=\"/treatment-summaries/platelet-disorders\" title=\"Platelet disorders\" count=\"2\" rel=\"backlink\">Platelet disorders</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74655\" namespace=\"/drugs/romiplostim/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP5930",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/romiplostim",
    "basename": "romiplostim",
    "title": "ROMIPLOSTIM",
    "vtmid": "441077008",
    "drugClassification": [
        "Thrombopoietin receptor agonists"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of chronic idiopathic thrombocytopenic purpura in splenectomised patients refractory to other treatments (such as corticosteroids or immunoglobulins) (under expert supervision)",
                        "html": "Treatment of chronic idiopathic thrombocytopenic purpura in splenectomised patients refractory to other treatments (such as corticosteroids or immunoglobulins) (under expert supervision)"
                    },
                    {
                        "textContent": "Second-line treatment of chronic idiopathic thrombocytopenic purpura in non-splenectomised patients when surgery is contra-indicated (under expert supervision)",
                        "html": "Second-line treatment of chronic idiopathic thrombocytopenic purpura in non-splenectomised patients when surgery is contra-indicated (under expert supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 1 microgram/kg once weekly, adjusted in steps of 1 microgram/kg once weekly (max. per dose 10 micrograms/kg once weekly) until a stable platelet count of 50x109 /litre or more is reached, discontinue treatment if inadequate response after 4 weeks at maximum dose, consult product literature for dose adjustments.",
                        "html": "<p>Initially 1&#8239;microgram/kg once weekly, adjusted in steps of 1&#8239;microgram/kg once weekly (max. per dose 10&#8239;micrograms/kg once weekly) until a stable platelet count of 50x10<sup>9</sup> /litre or more is reached, discontinue treatment if inadequate response after 4 weeks at maximum dose, consult product literature for dose adjustments.</p>"
                    }
                ]
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Arthralgia",
                        "html": "Arthralgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "asthenia",
                        "html": "asthenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bone pain",
                        "html": "bone pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "ecchymosis",
                        "html": "ecchymosis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal disturbances",
                        "html": "gastro-intestinal disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "increased bone marrow reticulin",
                        "html": "increased bone marrow reticulin",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "influenza-like symptoms",
                        "html": "influenza-like symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "injection site reactions",
                        "html": "injection site reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "migraine",
                        "html": "migraine",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscle spasm",
                        "html": "muscle spasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if essential&#8212; toxicity in animal studies.",
                "html": "<p>Manufacturer advises use only if essential&#8212; toxicity in <i>animal</i> studies.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in moderate or severe impairment unless potential benefit outweighs risk (e.g. of portal vein thrombosis).",
                "html": "<p>Avoid in moderate or severe impairment unless potential benefit outweighs risk (e.g. of portal vein thrombosis).</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution&#8212;no information available.",
                "html": "<p>Manufacturer advises caution&#8212;no information available.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor full blood count and peripheral blood smears for morphological abnormalities before and during treatment.\n\nMonitor platelet count weekly until 50x109 /litre or more for at least 4 weeks without dose adjustment, then monthly thereafter.",
                "html": "<p>Monitor full blood count and peripheral blood smears for morphological abnormalities before and during treatment.</p><p>Monitor platelet count weekly until 50x10<sup>9</sup> /litre or more for at least 4 weeks without dose adjustment, then monthly thereafter.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundDrivingAndOtherTasks": [
            {
                "type": "adviceAroundDrivingAndOtherTasks",
                "textContent": "Dizziness may affect performance of skilled tasks (e.g. driving).",
                "html": "<p>Dizziness may affect performance of skilled tasks (e.g. driving).</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA221",
                        "label": "www.nice.org.uk/TA221"
                    }
                ],
                "fundingIdentifier": "NICE TA221",
                "textContent": "Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (April 2011) Romiplostim is recommended for the treatment of chronic immune (idiopathic) thrombocytopenic purpura in adults: if the manufacturer provides romiplostin at the agreed discount as part of the patient access scheme and whose condition is refractory to standard active treatments and rescue therapies or who have severe disease and a high risk of bleeding that needs frequent courses of rescue therapies.\n\nwww.nice.org.uk/TA221",
                "html": "<p outputclass=\"title\">Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (April 2011)</p> <p>Romiplostim is recommended for the treatment of chronic immune (idiopathic) thrombocytopenic purpura in adults:</p> <ul> <li>if the manufacturer provides romiplostin at the agreed discount as part of the patient access scheme <i>and</i> </li> <li>whose condition is refractory to standard active treatments and rescue therapies <i>or</i> </li> <li>who have severe disease and a high risk of bleeding that needs frequent courses of rescue therapies.</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA221\">www.nice.org.uk/TA221</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74655",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78556",
                "label": "Platelet disorders",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74655",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}